NCT03000842

Brief Summary

The vagal stimulation is a promising therapy for a lot of disorders as well as hemodynamic regulatory way. In order to minimize the harm of a surgery chip implantation, actually it was developing a non-invasive device that is able to stimulate the auricular branch of vagal nerve. It has been shown that trans-auricular vagal stimulation (tVNS) causes direct stimulation of the vagal nerve. However, there are still no strong evidences about it actions regarding the autonomic modulation. The aim of this study is to evaluate effects of tVNS on heart rate, blood pressure and the autonomic control in healthy and hypertensive subjects, at rest and after orthostatic position

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable hypertension

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 22, 2016

Completed
10 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

December 22, 2016

Status Verified

December 1, 2016

Enrollment Period

2 months

First QC Date

December 20, 2016

Last Update Submit

December 21, 2016

Conditions

Keywords

autonomic controltranscutaneous vagal nerve stimulationtransauricular vagal nerve stimulation

Outcome Measures

Primary Outcomes (1)

  • Autonomic control response to transcutaneous vagal nerve stimulation

    sympathetic and parasympathetic response to non-invasive vagal nerve stimulation

    40 minutes

Secondary Outcomes (2)

  • Blood pressure changes to transcutaneous vagal nerve stimulation

    40 minutes

  • Heart Rate changes to transcutaneous vagal nerve stimulation

    40 minutes

Study Arms (2)

Healthy Subjects

EXPERIMENTAL

transcutaneous vagal nerve stimulation

Device: transcutaneous vagal nerve stimulation onDevice: transcutaneous vagal nerve stimulation off

Hypertensive Subjects

EXPERIMENTAL

transcutaneous vagal nerve stimulation

Device: transcutaneous vagal nerve stimulation onDevice: transcutaneous vagal nerve stimulation off

Interventions

electrical current on positioned in the ear to estimate vagal branch of auricular nerve

Healthy SubjectsHypertensive Subjects

an electrical current off positioned in the ear to estimate vagal branch of auricular nerve

Healthy SubjectsHypertensive Subjects

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy volunteers
  • sign the consent term

You may not qualify if:

  • smokers
  • alcoholism
  • drug treatment
  • skin lesion in the ear region
  • chronic or acute diseases
  • pregnancy
  • be participating in another research protocol
  • high performance athletes
  • recent surgery
  • vaso-vagal syndrome
  • hypertensive diagnosis (with or without anti-hypertensive drugs treatment) or
  • ambulatory blood pressure monitoring (ABPM) \>130/85
  • sign the consent term
  • smokers
  • alcoholism
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2016

First Posted

December 22, 2016

Study Start

January 1, 2017

Primary Completion

March 1, 2017

Study Completion

June 1, 2017

Last Updated

December 22, 2016

Record last verified: 2016-12